Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & Chief Operating Officer | November 27, 2023 | November 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date November 27, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,338 |
Ending reported balance
After 2023-11-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 6,479 Row 2 · 2023-11-27 · Tax withholding · Disposed 141 · Balance 6,338 F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 813 |
Reported balance
After 2023-11-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813 F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |
| Common StockSEC Table I · non-derivative | IndirectBerger Family Trust | 242 |
Reported balance
Holding disclosure · report date 2023-11-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 242 F2: The securities are held by the Berger Family Trust dated April 16, 2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2: The securities are held by the Berger Family Trust dated April 16, 2008.
F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2019 Filed Jan 9, 2019 22:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $40.08 | $400,751.00 |
DisclosureSEC source: 0001209191-19-003104 · doc4.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 F2 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018, in multiple transactions at prices ranging from $40.00 and $40.15. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 08, 2019 Filed Jan 9, 2019 22:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $2.59 | $25,900.00 |
DisclosureSEC source: 0001209191-19-003104 · doc4.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 23:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,493 | $34.85 | $52,031.05 |
DisclosureSEC source: 0001209191-18-061645 · doc4.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Indirect · Berger Family Trust Disclosed balance after: 200 F3 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2018, in multiple transactions at prices ranging from $34.8225 to $34.89. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F4 · ownership.nature: Shares are beneficially owned by the Berger Family Trust dated April 16, 2008(the "Trust"), with respect to which reporting person is a trustee. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 23:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $34.50 | $344,960.00 |
DisclosureSEC source: 0001209191-18-061645 · doc4.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 F2 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2018, in multiple transactions at prices ranging from $33.80 to $34.965. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 23:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $2.59 | $25,900.00 |
DisclosureSEC source: 0001209191-18-061645 · doc4.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares were acquired due to the exercise of a previously awarded stock option. Each share converts upon exercise into one share of common stock. Read SEC document |
| December 06, 2018 Filed Dec 14, 2018 00:30 UTC Amendment | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-18-062532 · doc4a.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: This amendment is being filed to reflect the exercise of the stock option award in Table II. F6 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. Read SEC document |
| December 06, 2018 Filed Dec 14, 2018 00:30 UTC Amendment | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,493 | $34.85 | $52,031.05 |
DisclosureSEC source: 0001209191-18-062532 · doc4a.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Indirect · Berger Family Trust Disclosed balance after: 200 F3 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018, in multiple transactions at prices ranging from $34.8225 to $34.89. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. F4 · ownership.nature: Shares are beneficially owned by the Berger Family Trust dated April 16, 2008, for which the Reporting Person is a trustee. Read SEC document |
| December 06, 2018 Filed Dec 14, 2018 00:30 UTC Amendment | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $34.50 | $344,960.00 |
DisclosureSEC source: 0001209191-18-062532 · doc4a.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 F2 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018, in multiple transactions at prices ranging from $33.80 to $34.965. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 06, 2018 Filed Dec 14, 2018 00:30 UTC Amendment | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $2.59 | $25,900.00 |
DisclosureSEC source: 0001209191-18-062532 · doc4a.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 965 | $16.92 | $16,327.80 |
DisclosureSEC source: 0001209191-18-059302 · doc4.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of June 15, 2018 through November 15, 2018. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 15, 2018. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 22:48 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 100,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-18-038166 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 6/14/2019 and the remainder in 12 equal monthly installments thereafter F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:55 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 80,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064028 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:00 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033630 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155749 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.